Showing results (431-440 of 470) with videos related to
Sort By:
Pageof 47
American Journal of Clinical Oncology|February 22, 2000
Ambamustine in the second-line treatment of patients with small-cell lung cancer: a phase II Fonicap studyA Ardizzoni, G Antonelli, S Ricci, et al.Surgical Endoscopy|September 17, 2002
Italian multicenter survey on laparoscopic treatment of gastro-esophageal reflux disease in childrenG Mattioli, C Esposito, M Lima, et al.Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO)C Tibaldi, S Ricci, F Russo, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 8, 2013
Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasmsS Caponi, E Vasile, N Funel, et al.La Clinica Terapeutica|December 7, 2017
Correlation between benzene and testosterone in workers exposed to urban pollutionM V Rosati, A Sancini, F Tomei, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 17, 2004
Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancersE Strocchi, R V Iaffaioli, G Facchini, et al.Annals of Neurology|February 9, 2000
Genetic and neuroradiological heterogeneity of double cortex syndromeJ G Gleeson, R F Luo, P E Grant, et al.Seminars in Oncology|June 1, 1997
A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancerC Manegold, P Drings, J von Pawel, et al.Pituitary|October 19, 2022
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) studyH Masri Iraqi, E Pigarova, S Zacharieva, et al.Vaccine|April 8, 2025
Considering recombinant herpes zoster vaccine for fragile pediatric patients: A new opportunityA Mollo, M Peri, L Lodi, et al.Pageof 47